Navigation Links
Governor O'Malley Announces State Grants Available For Maryland Bio Companies
Date:8/24/2010

BALTIMORE, Aug. 24 /PRNewswire-USNewswire/ -- Governor Martin O'Malley announced today that State grants are available in Fiscal Year 2011 through the Maryland Biotechnology Center to assist in commercializing promising research, encouraging bio companies to collaborate with academic institutions and expanding biotechnology resources.  The Governor also announced that seven Maryland bio companies and universities received $1.3 million in FY 2010 grants, which was the first year of funding.

"Biotechnology continues to be a key driver of Maryland's economy," said Governor O'Malley. "The high quality of the biotechnology projects supported by these awards, as well as their link to a number of Maryland institutions of higher learning, demonstrates Maryland's significant potential to commercialize our unparalleled academic research."

Applications for the Biotechnology Commercialization Awards and the Translational Research Awards must be submitted by September 15th to the Maryland Biotechnology Center (MBC), a part of the Maryland Department of Business and Economic Development (DBED), at www.marylandbiocenter.org.  These grants complement funding available through TEDCO's Maryland Technology Transfer and Commercialization Fund, the University of Maryland's Maryland Industrial Partnerships Program and DBED's Maryland Venture Fund programs.

In Fiscal Year 2010, the Biotechnology Commercialization Awards were made to three biotechnology companies to assist them in commercializing a product or service.  College Park-based Zymetis, received a $200,000 grant to advance their work in converting whey to fuel; Fyodor, based in Baltimore's BioPark, received $200,000 for the commercialization of their flagship product, the Urine Malaria Test; and InfraTrac, located at the Silver Spring Innovation Center, received $100,000 to grow their counterfeit
'/>"/>

SOURCE Maryland Department of Business and Economic Development
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Howard J. Leonhardt Announces Candidacy for Governor of California
2. GreenHouse Energy, Governor Schwarzenegger Join in Driving the Future of Fueling in California
3. Venture Capitalists to Invest in Promising PA Life Science Companies, Governor Rendell Says
4. The Biotechnology Industry Organization Honors Georgia Governor Sonny Perdue as Governor of the Year
5. Governor Rendell Says Life Science Industry Will Fuel New Breakthroughs, Generate Jobs for Decades to Come
6. Archimedes Pharma US Announces New US Headquarters In Bedminster, New Jersey
7. Sigma-Aldrich Announces Appointment of Magnus Borg as Vice President and Chief Information Officer (CIO)
8. 3SBio Inc. Announces Unaudited Second Quarter Results
9. SeqWright Announces the Addition of Illumina HiSeq 2000 to its Next Generation Sequencing Capabilities
10. Spherix Announces Second Quarter 2010 Financial Results
11. Ingenuity Systems Announces Toxicogenomics Best Practices White Paper
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2012)... 2012  Intellect Neurosciences, Inc. (OTCPK: ILNS) announces ... and CEO, will be presenting at the Seventh ... (Logo:  http://photos.prnewswire.com/prnh/20111214/NY22484LOGO ) The ... Neoepitopes Offer Attractive Targets for Active and Passive ... 21st at the Intercontinental Hotel in Boston from ...
(Date:5/16/2012)... LOUIS, May 16, 2012  Sigma-Aldrich announced today ... revolving credit facility that will mature on May ... million revolving credit facility that was scheduled to ... facility will provide back-up liquidity for the commercial ... purposes. Wells Fargo Securities LLC, Merrill ...
(Date:5/16/2012)... 2012 Reportlinker.com announces that ... available in its catalogue: , ... http://www.reportlinker.com/p090668/Global-Biotechnology-Instrumentation-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_ This ... Biotechnology Instrumentation in US$ Million by ... Protein/Peptide Synthesizers, DNA Sequencers, Protein/Peptide Sequencers, ...
(Date:5/15/2012)... taken a step toward overcoming a key ... could bring optical advances including ultrapowerful microscopes, ... have shown how to create the metamaterials ... required, said Alexandra Boltasseva, a Purdue University ... , Using the metals is impractical for ...
Breaking Biology Technology:Intellect Neurosciences, Inc. to Present at Neurotech Investing and Partnering Conference 2Intellect Neurosciences, Inc. to Present at Neurotech Investing and Partnering Conference 3Global Biotechnology Instrumentation Industry 2Global Biotechnology Instrumentation Industry 3Global Biotechnology Instrumentation Industry 4Global Biotechnology Instrumentation Industry 5Global Biotechnology Instrumentation Industry 6Global Biotechnology Instrumentation Industry 7Global Biotechnology Instrumentation Industry 8Global Biotechnology Instrumentation Industry 9Global Biotechnology Instrumentation Industry 10Global Biotechnology Instrumentation Industry 11Global Biotechnology Instrumentation Industry 12Global Biotechnology Instrumentation Industry 13Global Biotechnology Instrumentation Industry 14Global Biotechnology Instrumentation Industry 15Global Biotechnology Instrumentation Industry 16Global Biotechnology Instrumentation Industry 17Global Biotechnology Instrumentation Industry 18Global Biotechnology Instrumentation Industry 19Global Biotechnology Instrumentation Industry 20New 'metamaterial' practical for optical advances 2New 'metamaterial' practical for optical advances 3
... Feb. 23 GeneraMedix, Inc. announced,today that it ... its improved,formulation of epoprostenol sodium for the intravenous ... a biopharmaceutical company with,its headquarters in Allschwil/Basel, Switzerland. ... "This sale speaks directly ...
... a developer of a pharmacogenomic test to identify potential ... Lilly and Company under the trademark Xigris (R)), announced ... at the annual Invest Northwest Investor-CEO forum conference on ... is presented by the Washington Biotechnology & Biomedical Association ...
... NEW YORK, Feb. 23 /PRNewswire-Asia-FirstCall/ -- American Oriental,Bioengineering, Inc. ... plans to release,fourth quarter and full year 2008 financial ... , The Company will hold ... 9, 2009 to,discuss fiscal fourth quarter and full year ...
Other Biology Technology:GeneraMedix, Inc. Announces Sale of Innovative Epoprostenol Formulation to Actelion Ltd. 2GeneraMedix, Inc. Announces Sale of Innovative Epoprostenol Formulation to Actelion Ltd. 3Sirius Genomics to Present at Invest Northwest Conference 2
(Date:5/20/2012)... May 2012. The Stem Cells and Cancer Research ... the Vall d,Hebrn Institute of Oncology (VHIO) has ... to certain drugs used in clinical trials for ... also benefited from the collaboration with Professor Alberto ... Alberto Sols, Consejo Superior de Investigaciones Cientficas (IIB-CSIC-Madrid). ...
(Date:5/18/2012)... /PRNewswire-iReach/ -- With chronic diseases continuing to ... and research to find "cures" continuing to take ... "a few years away," a small but growing ... the human consciousness. A number of healing practices ... geometry, and intention, have emerged, embracing practices first ...
(Date:5/18/2012)... McCauley and Paul DeSalles did not set out to ... documented. But that,s exactly what they and a team ... and faculty did in a new study published ... light on how human disturbance of the natural world ... ecological interaction chains. This, in turn, highlights the need ...
Breaking Biology News(10 mins):Discovery of mechanisms predicting response to new treatments in colon cancer 2Discovery of mechanisms predicting response to new treatments in colon cancer 3Healing Method from Australia Addresses the Human Genome 2Stanford scientists document fragile land-sea ecological chain 2Vivakor Confirms Record Date of Stock Dividend 15068 1Vivakor Confirms Record Date of Stock Dividend 15068 2Vivakor Confirms Record Date of Stock Dividend 15068 3Amber Pharmacy Earns Accreditation From ACHC 6764 1Amber Pharmacy Earns Accreditation From ACHC 6764 2Cholesterol lowering drugs also may protect stem cell transplant patients from GVHD 62638 1Cholesterol lowering drugs also may protect stem cell transplant patients from GVHD 62638 2
... researchers led by the Smithsonian Institution has completed a ... the hobbit, a 3-foot-tall, 18,000-year-old hominin skeleton, discovered four ... study offers one of the most striking confirmations of ... remnant of one of the oldest human migrations to ...
... recently discovered that a chemical chain reaction that controls ... could mean the difference between normal growth and cancer. ... Cell, describes how organs can grow uncontrollably huge and ... , This chain reaction, a domino-like chain of events ...
... HONOLULU, Sept. 20 Women with low levels of vitamin ... a study led by the University of Pittsburgh Graduate School ... meeting of the American Society for Bone and Mineral Research ... professor of epidemiology, and colleagues evaluated patient data on 400 ...
Other Biology News:New research sheds light on 'Hobbit' 2Controlling for size may also prevent cancer 2Low vitamin D linked to higher risk of hip fracture 2
Anti-Chicken IgY, (IgG) F(ab')2 Fragment Specific....
Presenilin 2 Immunogen: Synthetic peptide corresponding to residues 31-47 of human Presenilin 2. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Recognizes TWIK-2. Does not cross react with any other known proteins....
Sheep polyclonal to ErbB 2 ( Abpromise for all tested applications). Antigen: Recombinant full length c-ErbB2 protein (Human). Entrez GeneID: 2064 Swiss Protein ID: P04626...
Biology Products: